Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Hertlein

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Plos One|October 17, 2013
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to diseaseErin Hertlein, Kyle A Beckwith, Gerard Lozanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
Blood Advances|September 30, 2024
CD37 in acute myeloid leukemia: a novel surface target for drug deliveryErin Jeremy, Esthela Artiga, Sara Elgamal, et al.
JCI Insight|December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemiaJae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
<i>PTPN11</i> Mutation Clonal Hierarchy in Acute Myeloid LeukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
JCI Insight|February 23, 2026
Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
JCI Insight|April 22, 2024
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemiaOla A Elgamal, Sydney Fobare, Sandip Vibhute, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Plos One|October 17, 2013
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to diseaseErin Hertlein, Kyle A Beckwith, Gerard Lozanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
Blood Advances|September 30, 2024
CD37 in acute myeloid leukemia: a novel surface target for drug deliveryErin Jeremy, Esthela Artiga, Sara Elgamal, et al.
JCI Insight|December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemiaJae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
<i>PTPN11</i> Mutation Clonal Hierarchy in Acute Myeloid LeukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
JCI Insight|February 23, 2026
Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
JCI Insight|April 22, 2024
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemiaOla A Elgamal, Sydney Fobare, Sandip Vibhute, et al.
Pageof 5